NCT06394427View on ClinicalTrials.gov

Neoadjuvant Chemoimmunotherapy in Stage IIIA- N2IIIB Non-small Cell Lung Cancer

Not yet recruitingOBSERVATIONAL
Enrollment

250

Participants

Timeline

Start Date

May 31, 2024

Primary Completion Date

August 31, 2024

Study Completion Date

August 31, 2025

Conditions
Non-small Cell Lung Cancer Stage ⅢANon-small Cell Lung Cancer Stage IIIB
Interventions
OTHER

cycles of neoadjuvant therapy and duration of waiting for surgery

We intended to explore the cycles of neoadjuvant therapy and duration of waiting for surgery on the perioperative outcomes and long-term prognosis of locally advanced NSCLC in the real world

All Listed Sponsors
lead

West China Hospital

OTHER

NCT06394427 - Neoadjuvant Chemoimmunotherapy in Stage IIIA- N2IIIB Non-small Cell Lung Cancer | Biotech Hunter | Biotech Hunter